TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE
6.1. Overview
6.2. Transfemoral Implantation
6.3. Transapical Implantation
6.4. Transaortic Implantation
7. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER
7.1. Overview
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Others
8. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Transcatheter Aortic Valve Replacement (TAVR) Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Transcatheter Aortic Valve Replacement (TAVR) Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger &Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure.2023
10. COMPANY PROFILES
10.1. CryoLife, Inc. (U.S.)
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Abbott (U.S.)
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Micro Interventional Devices, Inc. (U.S.).
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Boston Scientific Corporation (U.S.)
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. LIVANOVA PLC (U.K.)
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Meril Life Sciences Pvt. Ltd. (India)
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Edwards Lifesciences Corporation (U.S.)
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Medtronic (Ireland)
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Auto Tissue Berlin GmbH (Germany)
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Lepu Medical Technology Co. Ltd. (China)
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Neovasc Inc. (Canada)
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. TTK HealthCare (India)
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Products Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. JenaValve Technology, Inc. (Germany)
10.13.1. Company Overview
10.13.2. Financial Overview
10.13.3. Products Offered
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, ESTIMATES &FORECAST, 2019-2032(USD BILLION)
TABLE 3 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 US: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 8 US: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 CANADA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 10 CANADA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 ITALY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 8 ITALY: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 UK: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 12 UK: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 CHINA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 20 CHINA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 21 INDIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 22 INDIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY PROCEDURE, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET
FIGURE 4 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY PROCEDURE, 2023
FIGURE 5 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY END USER, 2023
FIGURE 6 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 CRYOLIFE, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 CRYOLIFE, INC. (U.S.): SWOT ANALYSIS
FIGURE 14 ABBOTT (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ABBOTT (U.S.): SWOT ANALYSIS
FIGURE 16 MICRO INTERVENTIONAL DEVICES, INC. (U.S.).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 MICRO INTERVENTIONAL DEVICES, INC. (U.S.).: SWOT ANALYSIS
FIGURE 18 BOSTON SCIENTIFIC CORPORATION (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BOSTON SCIENTIFIC CORPORATION (U.S.): SWOT ANALYSIS
FIGURE 20 LIVANOVA PLC (U.K.).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 LIVANOVA PLC (U.K.): SWOT ANALYSIS
FIGURE 22 MERIL LIFE SCIENCES PVT. LTD. (INDIA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERIL LIFE SCIENCES PVT. LTD. (INDIA): SWOT ANALYSIS
FIGURE 24 EDWARDS LIFESCIENCES CORPORATION (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 EDWARDS LIFESCIENCES CORPORATION (U.S.): SWOT ANALYSIS
FIGURE 26 MEDTRONIC (IRELAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MEDTRONIC (IRELAND): SWOT ANALYSIS
FIGURE 28 AUTO TISSUE BERLIN GMBH (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 AUTO TISSUE BERLIN GMBH (GERMANY): SWOT ANALYSIS
FIGURE 30 LEPU MEDICAL TECHNOLOGY CO. LTD. (CHINA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 LEPU MEDICAL TECHNOLOGY CO. LTD. (CHINA): SWOT ANALYSIS
FIGURE 32 NEOVASC INC. (CANADA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 NEOVASC INC. (CANADA): SWOT ANALYSIS
FIGURE 34 TTK HEALTHCARE (INDIA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 TTK HEALTHCARE (INDIA): SWOT ANALYSIS
FIGURE 36 JENAVALVE TECHNOLOGY, INC. (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 JENAVALVE TECHNOLOGY, INC. (GERMANY): SWOT ANALYSIS